Trial Profile
An open label, randomised study to evaluate the effects of vildagliptin on kidney dysfunction markers in patients with type-2 diabetes
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Mar 2016
Price :
$35
*
At a glance
- Drugs Vildagliptin (Primary) ; Insulin
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacodynamics
- 23 Mar 2016 New trial record